Figure 4.

Map of SV40 nucleic acid detection and historical vaccine contamination with SV40 in European countries. For nucleic acid detection a cut-off level of 10% (SV40 positive samples from a country of total examined samples) was chosen.

Leithner et al. Orphanet Journal of Rare Diseases 2006 1:44   doi:10.1186/1750-1172-1-44
Download authors' original image